Compare RM & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RM | LAB |
|---|---|---|
| Founded | 1987 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 334.1M | 347.5M |
| IPO Year | 2011 | 2008 |
| Metric | RM | LAB |
|---|---|---|
| Price | $42.11 | $0.91 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $30.00 | $1.35 |
| AVG Volume (30 Days) | 53.4K | ★ 6.1M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.12% | N/A |
| EPS Growth | 7.49 | ★ 61.54 |
| EPS | ★ 1.18 | 0.33 |
| Revenue | ★ $645,598,000.00 | $101,937,000.00 |
| Revenue This Year | $12.94 | N/A |
| Revenue Next Year | $8.97 | $2.63 |
| P/E Ratio | $35.31 | ★ $2.77 |
| Revenue Growth | ★ 9.70 | N/A |
| 52 Week Low | $30.46 | $0.70 |
| 52 Week High | $46.00 | $1.72 |
| Indicator | RM | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 69.81 | 52.79 |
| Support Level | $35.76 | $0.90 |
| Resistance Level | N/A | $1.02 |
| Average True Range (ATR) | 1.40 | 0.07 |
| MACD | 0.46 | 0.01 |
| Stochastic Oscillator | 79.86 | 92.80 |
Regional Management Corp is a diversified consumer finance company that provides installment loan products to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders. The company is engaged in consumer finance. The company has the core products which are small and large installment loans. The company also offers optional payment and collateral protection insurance. The company's principal source of revenue is interest and fee income on outstanding loans.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.